Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8907 | 1138 | 26.8 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
80 | 26597 | ASPERGILLOSIS//VORICONAZOLE//AMPHOTERICIN B |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FLUCONAZOLE | Author keyword | 27 | 13% | 17% | 193 |
2 | FOSFLUCONAZOLE | Author keyword | 9 | 83% | 0% | 5 |
3 | MICRODILUTION TEST | Author keyword | 8 | 100% | 0% | 5 |
4 | OROPHARYNGEAL CANDIDIASIS | Author keyword | 7 | 31% | 2% | 19 |
5 | CLIN PHARMACOLSHIBUYA KU | Address | 6 | 80% | 0% | 4 |
6 | D0870 | Author keyword | 5 | 63% | 0% | 5 |
7 | CAS 86386 73 4 | Author keyword | 4 | 67% | 0% | 4 |
8 | RENAL DRUG ELIMINATION | Author keyword | 4 | 75% | 0% | 3 |
9 | MICRODILUTION | Author keyword | 3 | 21% | 1% | 14 |
10 | INVITRO SUSCEPTIBILITY | Author keyword | 2 | 44% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FLUCONAZOLE | 27 | 13% | 17% | 193 | Search FLUCONAZOLE | Search FLUCONAZOLE |
2 | FOSFLUCONAZOLE | 9 | 83% | 0% | 5 | Search FOSFLUCONAZOLE | Search FOSFLUCONAZOLE |
3 | MICRODILUTION TEST | 8 | 100% | 0% | 5 | Search MICRODILUTION+TEST | Search MICRODILUTION+TEST |
4 | OROPHARYNGEAL CANDIDIASIS | 7 | 31% | 2% | 19 | Search OROPHARYNGEAL+CANDIDIASIS | Search OROPHARYNGEAL+CANDIDIASIS |
5 | D0870 | 5 | 63% | 0% | 5 | Search D0870 | Search D0870 |
6 | CAS 86386 73 4 | 4 | 67% | 0% | 4 | Search CAS+86386+73+4 | Search CAS+86386+73+4 |
7 | RENAL DRUG ELIMINATION | 4 | 75% | 0% | 3 | Search RENAL+DRUG+ELIMINATION | Search RENAL+DRUG+ELIMINATION |
8 | MICRODILUTION | 3 | 21% | 1% | 14 | Search MICRODILUTION | Search MICRODILUTION |
9 | INVITRO SUSCEPTIBILITY | 2 | 44% | 0% | 4 | Search INVITRO+SUSCEPTIBILITY | Search INVITRO+SUSCEPTIBILITY |
10 | IMMUNOSTATUS | 2 | 67% | 0% | 2 | Search IMMUNOSTATUS | Search IMMUNOSTATUS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BROTH MACRODILUTION | 72 | 69% | 5% | 62 |
2 | NATIONAL COMMITTEE | 32 | 40% | 5% | 62 |
3 | MACRODILUTION | 24 | 51% | 3% | 34 |
4 | RECURRENT ORAL CANDIDIASIS | 18 | 83% | 1% | 10 |
5 | UK 49 858 | 18 | 49% | 2% | 26 |
6 | CLOTRIMAZOLE TROCHES | 17 | 68% | 1% | 15 |
7 | OROPHARYNGEAL CANDIDIASIS | 16 | 18% | 7% | 79 |
8 | ALBICANS RESISTANCE | 15 | 88% | 1% | 7 |
9 | FLUCONAZOLE RESISTANT CANDIDA | 14 | 39% | 3% | 29 |
10 | BROTH MACRODILUTION METHOD | 11 | 50% | 1% | 16 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro in vivo correlation data for fluconazole, itraconazole, and Candida infections | 1997 | 504 | 92 | 49% |
RESISTANCE OF CANDIDA SPECIES TO FLUCONAZOLE | 1995 | 583 | 51 | 63% |
Antifungal susceptibility testing: Practical aspects and current challenges | 2001 | 212 | 202 | 44% |
Susceptibility testing of fungi: Current status of correlation of in vitro data with clinical outcome | 1996 | 131 | 64 | 77% |
Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability | 2011 | 6 | 18 | 50% |
FLUCONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL AND SYSTEMIC MYCOSES | 1990 | 341 | 55 | 56% |
Review of Fluconazole Properties and Analytical Methods for Its Determination | 2011 | 4 | 40 | 60% |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients | 2001 | 33 | 28 | 82% |
Standardization of antifungal susceptibility testing | 1996 | 36 | 65 | 77% |
Mucosal candidiasis | 2002 | 43 | 66 | 32% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN PHARMACOLSHIBUYA KU | 6 | 80% | 0.4% | 4 |
2 | ANN ARBOR VET AFFAIRS HLTH SYST INFECT DIS | 1 | 50% | 0.1% | 1 |
3 | ATTIKON HOSPRIMINI HAIDARI 1 | 1 | 50% | 0.1% | 1 |
4 | HOPE HOSP MED INFECT DIS SECT | 1 | 50% | 0.1% | 1 |
5 | INFECT DIS PL5 | 1 | 50% | 0.1% | 1 |
6 | KAROLINSKA HOSP L2 02 | 1 | 50% | 0.1% | 1 |
7 | MED VIRGINIA INFECT DIS | 1 | 50% | 0.1% | 1 |
8 | NEW MULAGO HOSP | 1 | 50% | 0.1% | 1 |
9 | POLICLIN SANTORSOLA | 1 | 50% | 0.1% | 1 |
10 | UNIDAD FARMACOL CLIN EXPT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000234188 | SAPERCONAZOLE//BROMUCONAZOLE//MICONAZOLE SULFOSALICYLATE |
2 | 0.0000209529 | VORICONAZOLE//HYDROXYITRACONAZOLE//POSACONAZOLE |
3 | 0.0000199773 | CANDIDEMIA//CANDIDAEMIA//ANIDULAFUNGIN |
4 | 0.0000180376 | CYP51A//ISAVUCONAZOLE//AZOLE RESISTANCE |
5 | 0.0000158719 | CANDIDA DUBLINIENSIS//CANDIDA AFRICANA//C DUBLINIENSIS |
6 | 0.0000144361 | CYTOCHROME P450 INTERACTIONS//NONLINEAR CLEARANCE//NONLINEAR LIVER BINDING |
7 | 0.0000135069 | CDR1//PDR5//PLEIOTROPIC DRUG RESISTANCE |
8 | 0.0000115129 | OPTICALLY ACTIVE ANTIFUNGAL AZOLE//BIOORGAN MED CHEM//CS 758 |
9 | 0.0000107948 | PRADIMICIN//FR901379//BENANOMICIN |
10 | 0.0000103548 | CANDIDURIA//FUNGURIA//CONGENITAL CANDIDIASIS |